Nephrocare Health Services enterprise value

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast closeFY26Mar 2026
6,305—
295295
79.779.7
6,091—
−215−215
₹606.99—
1,1961,196
6.7%6.7%
0.01×—
6.10×—
26.83×—
44.69×—
26.19×—
53.80×—
55.66×—
Reference items — trailing FY values
999999
227227
136136
233233
113113
109109
119119
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NEPHROPLUS₹628.40

Nephrocare Health Services Limited

· Pharma & Health
₹ CrorePeersKRSNAASURAKSHAHEALTHX3BBLACKBIOMcap ₹6,305 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Current
last close
Market Capitalization—6,305.4
- Cash, Equiv & ST Investments294.5294.5
+ Total Debt79.779.7
Enterprise Value—6,090.5
Net Debt (memo)-214.8-214.8
EV per Share—606.99
Total Capital1,196.21,196.2
Total Debt/Total Capital6.666.66
Total Debt/EV—0.01
EV/Sales—6.10
EV/EBITDA—26.83
EV/EBIT—44.69
EV/Operating Cash Flow—26.19
EV/Free Cash Flow—53.80
EV/FCFF—55.66
Reference Items — Trailing FY Values
Sales998.8998.8
EBITDA227.0227.0
EBIT136.3136.3
Operating Cash Flow232.6232.6
Free Cash Flow113.2113.2
FCFF (free cash flow to the firm)109.4109.4
Capital Expenditure119.4119.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.